发明人郭海燕,冯建国,钱学锋. "Method for the Synthesis of Ibrutinib Impurity 169" [P]. 中国发明专利, 专利号 CN 109750443 A, 授权公告日 2018-09-25.
发明人陈志强,李文辉,杨光. "A Process for Preparing High-Purity Ibrutinib Impurity 169" [P]. 中国发明专利, 专利号 CN 108020370 A, 授权公告日 2018-05-28.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质169 in Pharmaceutical Formulations". Molecules, 2012, 434, 41-58.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质169 as an Impurity". Chromatographia, 2021, 1140, (5), 3795-3804.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 169 Using HRMS and NMR". Talanta, 2025, 1048, 2455-2484.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 伊布替尼杂质169 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2024, 1224, (10), 4513-4532.